In the Chinese population, as compared with sporadic breast cancer, BRCA1-associated breast cancer had a higher pathologic grade, and higher percentages of CerbB-2-negative and triple negative (ER/PR/CerbB-2-negative) tumors. This evidence concerns the gene BRCA1 and breast carcinoma.